These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23163746)

  • 21. [In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide].
    Tu LX; Xu YH; Tang CY; Deng LH; Wu CB
    Yao Xue Xue Bao; 2012 May; 47(5):646-51. PubMed ID: 22812011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
    Duan C; Gao J; Zhang D; Jia L; Liu Y; Zheng D; Liu G; Tian X; Wang F; Zhang Q
    Biomacromolecules; 2011 Dec; 12(12):4335-43. PubMed ID: 22077387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles.
    Mei Y; Xu J; Zhao J; Feng N; Liu Y; Wei L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):138-41. PubMed ID: 18514594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
    Xing J; Zhang D; Tan T
    Int J Biol Macromol; 2007 Jan; 40(2):153-8. PubMed ID: 16901536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Circulating and Brain-Targeted Liposomes Loaded with Isoliquiritigenin: Formation, Characterization, Pharmacokinetics, and Distribution.
    Song W; Bai L; Xu P; Zhao Y; Zhou X; Xiong J; Li X; Xue M
    Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redox-sensitive irinotecan liposomes with active ultra-high loading and enhanced intracellular drug release.
    Wang T; He W; Du Y; Wang J; Li X
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111967. PubMed ID: 34256270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galactosylated Chitosan Coated Liposomes of Ledipasvir for Liver Targeting: Chemical Synthesis, Statistical Optimization, In-vitro and In-vivo evaluation.
    Fatouh AM; Elshafeey AH; Abdelbary A
    J Pharm Sci; 2021 Mar; 110(3):1148-1159. PubMed ID: 33039437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
    Lou H; Gao L; Wei X; Zhang Z; Zheng D; Zhang D; Zhang X; Li Y; Zhang Q
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):319-25. PubMed ID: 21676599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
    Wang J; Huang G
    Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
    Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
    Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of liposomal breviscapine in brain following intravenous injection in rats.
    Lv W; Guo J; Li J; Huang L; Ping Q
    Int J Pharm; 2005 Dec; 306(1-2):99-106. PubMed ID: 16280216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental research on the mechanisms of human multiple myeloma LP-1 cell apoptosis induced by oridonin].
    Zhao J; Zhang M; Chen Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1642-6. PubMed ID: 23469604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antitumor activity of oridonin nanosuspension.
    Lou H; Zhang X; Gao L; Feng F; Wang J; Wei X; Yu Z; Zhang D; Zhang Q
    Int J Pharm; 2009 Sep; 379(1):181-6. PubMed ID: 19563872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.
    Xu H; He C; Liu Y; Jiang J; Ma T
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1902-1907. PubMed ID: 29081246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
    Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
    Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation of freeze-dried long-circulation oridonin liposomes and their pharmacokinetics in rats].
    Lin H; Qu C; Yu Y; Tang Y; Sun X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 42(6):638-43. PubMed ID: 24421229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
    Feng C; Li X; Dong C; Zhang X; Zhang X; Gao Y
    Drug Des Devel Ther; 2015; 9():4613-20. PubMed ID: 26316700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of paraoxonase liposomes and their pharmacokinetics in rats].
    Han Z; Jiang S; Fu B; Zhao M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1021-1025. PubMed ID: 29151419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.